Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

GeoVax Labs collaborates with American Gene Technologies on functional cure for HIV

March 15, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

March 14, 2017

Theratechnologies acquires commercial rights to ibalizumab in E.U. and other countries

March 6, 2017

Hetero Research Foundation discloses novel antiviral agents

March 2, 2017

Promising results from the BCN02-Romi study of MVA.HIVconsv vaccine

March 2, 2017

GS-PI-1 is a promising new generation HIV PI with favorable potency and resistance barrier

March 2, 2017

ViiV Healthcare patents HIV integrase inhibitors

Feb. 27, 2017

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Feb. 24, 2017

UB-421 monotherapy shows promise for HAART substitution

Feb. 23, 2017

Gilead tests novel non-catalytic site integrase inhibitor GS-9822 in vivo

Feb. 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...